Santosh Gupta

772 total citations
15 papers, 246 citations indexed

About

Santosh Gupta is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Santosh Gupta has authored 15 papers receiving a total of 246 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 8 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Santosh Gupta's work include Prostate Cancer Treatment and Research (11 papers), Cancer Genomics and Diagnostics (7 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Santosh Gupta is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Cancer Genomics and Diagnostics (7 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Santosh Gupta collaborates with scholars based in United States, United Kingdom and France. Santosh Gupta's co-authors include Andrew J. Armstrong, Daniel J. George, Simon G. Gregory, Tian Zhang, Yuan Wu, Gabor Kemeny, Matthew D. Tucker, Rajan T. Gupta, Michael R. Harrison and Jason Zhu and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Santosh Gupta

14 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Santosh Gupta United States 6 163 122 106 73 30 15 246
Iben Lyskjær Denmark 11 134 0.8× 81 0.7× 158 1.5× 146 2.0× 49 1.6× 17 297
Yeonhwa Jung South Korea 6 92 0.6× 93 0.8× 68 0.6× 140 1.9× 23 0.8× 6 238
Núria Jordana‐Ariza Spain 7 139 0.9× 129 1.1× 193 1.8× 119 1.6× 41 1.4× 12 262
Eirini Biziota Greece 8 76 0.5× 158 1.3× 147 1.4× 151 2.1× 29 1.0× 18 319
Nobuhiko Nishijima Japan 8 143 0.9× 110 0.9× 79 0.7× 133 1.8× 20 0.7× 15 302
Rebeca Martínez Spain 6 183 1.1× 195 1.6× 138 1.3× 111 1.5× 58 1.9× 8 326
Giovanni Burrafato Italy 9 139 0.9× 157 1.3× 96 0.9× 64 0.9× 35 1.2× 13 247
Emily S. Weg United States 6 204 1.3× 82 0.7× 107 1.0× 63 0.9× 19 0.6× 23 266
Zixin Guo China 9 129 0.8× 59 0.5× 99 0.9× 111 1.5× 15 0.5× 19 220
Kakeru Hisakane Japan 10 215 1.3× 179 1.5× 67 0.6× 77 1.1× 10 0.3× 35 336

Countries citing papers authored by Santosh Gupta

Since Specialization
Citations

This map shows the geographic impact of Santosh Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Santosh Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Santosh Gupta more than expected).

Fields of papers citing papers by Santosh Gupta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Santosh Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Santosh Gupta. The network helps show where Santosh Gupta may publish in the future.

Co-authorship network of co-authors of Santosh Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of Santosh Gupta. A scholar is included among the top collaborators of Santosh Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Santosh Gupta. Santosh Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Wang, Jue, Noura Radwan, Catherine H. Marshall, et al.. (2024). Assessment of Circulating Tumor Cells in Oligometastatic Castration-Sensitive Prostate Cancer Patients from the ORIOLE Trial. International Journal of Radiation Oncology*Biology*Physics. 120(2). S68–S68. 1 indexed citations
3.
Gupta, Santosh, David Bourdon, Anis Hamid, et al.. (2024). Detection of PSMA expression on circulating tumor cells by blood-based liquid biopsy in prostate cancer. PubMed. 13(1). 1–6. 3 indexed citations
4.
Deek, Matthew P., Noura Radwan, Catherine H. Marshall, et al.. (2023). Prospective Characterization of Circulating Tumor Cells in Hormone Sensitive Oligometastatic Prostate Cancer Patients on a Metastasis-Directed Therapy Trial. International Journal of Radiation Oncology*Biology*Physics. 117(2). e367–e368. 1 indexed citations
5.
Zhang, Jiaren, Giuseppe Galletti, Susan Halabi, et al.. (2022). Association of circulating tumor cell RB1 loss RNA signature with outcomes and immune phenotypes in men with mCRPC.. Journal of Clinical Oncology. 40(6_suppl). 139–139.
6.
Gupta, Santosh, Susan Halabi, Gabor Kemeny, et al.. (2021). Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer. Molecular Cancer Research. 19(6). 1040–1050. 19 indexed citations
7.
Brown, Landon C., Matthew D. Tucker, Ramy Sedhom, et al.. (2021). LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types. Journal for ImmunoTherapy of Cancer. 9(3). e001792–e001792. 73 indexed citations
8.
Gupta, Santosh, Susan Halabi, Gabor Kemeny, et al.. (2020). Circulating tumor cell (CTC) genomic signatures of hormone therapy resistance in men with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 38(6_suppl). 147–147. 1 indexed citations
9.
Tucker, Matthew D., Jason Zhu, Daniele Marin, et al.. (2019). Pembrolizumab in men with heavily treated metastatic castrate‐resistant prostate cancer. Cancer Medicine. 8(10). 4644–4655. 59 indexed citations
10.
Zhu, Jason, Matthew D. Tucker, Chester Kao, et al.. (2019). Immune checkpoint inhibitor response in tumors with LRP1B variants.. Journal of Clinical Oncology. 37(15_suppl). e14291–e14291. 2 indexed citations
11.
Gupta, Santosh, Daniel H. Hovelson, Gabor Kemeny, et al.. (2019). Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer. Genes Chromosomes and Cancer. 59(4). 225–239. 22 indexed citations
12.
Armstrong, Andrew J., Susan Halabi, Jun Luo, et al.. (2018). The PROPHECY trial: Multicenter prospective trial of circulating tumor cell (CTC) AR-V7 detection in men with mCRPC receiving abiraterone (A) or enzalutamide (E).. Journal of Clinical Oncology. 36(15_suppl). 5004–5004. 10 indexed citations
13.
Armstrong, Andrew J., Santosh Gupta, Patrick Healy, et al.. (2018). Genomic and phenotypic evidence for prostate cancer osteomimicry in circulating tumor cells from men with metastatic castration resistant prostate cancer (mCRPC) treated with radium-223.. Journal of Clinical Oncology. 36(6_suppl). 160–160. 1 indexed citations
14.
Gupta, Santosh, Jing Li, Gabor Kemeny, et al.. (2016). Whole Genomic Copy Number Alterations in Circulating Tumor Cells from Men with Abiraterone or Enzalutamide-Resistant Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 23(5). 1346–1357. 52 indexed citations
15.
Gupta, Santosh. (1979). Lymphocyte functions in cancer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 79(6). 856–63. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026